BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
North West London Pathology & South West London Pathology are jointly seeking to understand market capacity and supplier capability in relation to a future procurement for a Pathology IT Laboratory Information Management System (LIMS) solution and associated implementation, migration, integration, training and support services. The purpose of this early market engagement is to inform the Authority on available market solutions, delivery approaches, implementation risks, commercial models, and opportunities to further strengthen NWLP’s and SWLP's pathology operating model.
Both NWLP and SWLP’s current state demonstrates a thriving, high-performing pathology network, but also one operating at scale and under continued transformation. The networks have highlighted sustained testing growth, increasing operational complexity, ongoing investment in digital pathology and automation, and the need for resilient infrastructure, strong interoperability beyond the traditional HL7 messaging and future-proofed digital capability. Both NWLP and SWLP laboratories support large-scale hub and spoke operations, urgent and routine testing pathways, a wide range of specialist diagnostics, and extensive GP and community connectivity.
A future of an Interoperable LIMS procurement is therefore anticipated to support both NWLP and SWLP in maintaining clinical safety, standardisation, regulatory compliance, operational performance while enabling further digital transformation and leveraging artificial intelligence and machine learning to support the future delivery of pathology and diagnostic services. Both NWLP and SWLP wishes to understand how the market can support disciplines including biochemistry, haematology, blood transfusion, microbiology, immunology, H&I, virology, cellular pathology, andrology, genetics and molecular workflows; provide robust interfaces into EPRs, national systems, automation platforms and analytics tools; and deliver a scalable platform aligned with NWLP and SWLP’s strategic direction.
Suppliers who are interested in this opportunity should complete the attached questionnaire and respond back by 1st October 2026 at 12 noon. To access the opportunity, please use Atamis via contract reference C467704 https://atamis-1928--prospend.vf.force.com/apex/CS_ContractPage?filters=&page=1&Preview=Yes&searchStr=&SearchType=Projects&sortStr=Alphabetical&uid=a07Pz00001e3fTKIAY&sfdcIFrameOrigin=https%3A%2F%2Fatamis-1928.lightning.force.com
Preliminary market engagement notice (UK2). The buyer wants to talk to suppliers before designing the procurement. Taking part is how to shape it.
Bids are submitted through the buyer’s own portal, not on this site. Read the full notice on Find a Tender before relying on any date here.
No supplier information available.
This procurement was divided into 1 lots, each awarded separately.
| Lot | Value | Status |
|---|---|---|
| Lot 1 Sept 2028 – Aug 2038 | - | planning |